The Top 100 U.S. In-Vitro Diagnostics Companies

Publisher Name :
Date: 13-Sep-2016
No. of pages: 210

Did you know?


  • Nova Biomedical is the largest privately owned in-vitro diagnostic company in the United States.

  • As of December 31, 2015, Exact Sciences Corporation had 677 full-time employees.

  • Sandy Athenson is Vice President & General Manager, Transfusion Diagnostics at Immucor, Inc..

  • In August, 2016, Alere Inc. received FDA Clearance for its Alere™ i RSV test, the first rapid molecular test that can be used at the point-of-care to detect RSV infection in 13 minutes or less.

  • As of December 31, 2015, more than 19,000 physicians in over 70 countries had ordered OncotypeDX gene expression tests from Genomic Health, Inc. which have been used to guide treatment decisions for more than 600,000 cancer patients worldwide.

  • In January, 2016, Banyan Biomarkers, Inc. and Royal Philips announced that they had entered into a multi-year joint development agreement to develop and commercialise a new handheld blood test to detect and evaluate mild traumatic brain injury at the point-of-care.

  • For the year ended December 31, 2015, Cepheid reported revenue of $538.6 million.


These are just a tiny sample of the 1,000's of facts to be found in ‘The Top 100 U.S. In-Vitro Diagnostics Companies'.

This unique and comprehensive report profiles the top 100 U.S. manufacturers of in-vitro diagnostics. These global leaders are continually developing new and innovative products to add to their already comprehensive portfolios. They are located right across the United States and have highly effective worldwidecommercial networks.

Profile information for each company in ‘The Top 100 U.S. In-Vitro Diagnostics Companies'typically includes:


  • Company Contact Information - Address, Telephone and Fax Numbers, Email and Website Addresses

  • Key Company Decision Makers - From CEO and Main Board, to Key Senior Managers

  • Specialised fields such as Company Description, Ownership, Products, Clinical Specialties/Diseases, Diagnostic Disciplines, Revenue, Year Established and Number of Employees.


Report Target Market:

1) IVD Manufacturers


  • Usage: competitive/financial analysis and strategic partner/alliance identification


2) IVD Suppliers


  • ‘The Top 100 U.S. In-Vitro Diagnostics Companies' is perfect for suppliers of goods and services such as components and sub-assemblies and development, design and manufacturing services who wish to identify top potential customers.


3) IVD Distributors


  • The report is very useful to IVD distributors to identifythe leading U.S. in-vitro diagnostics companies withthe best products.


Note: Most people will be aware of some of the major U.S. in-vitro diagnostics companies such as ACON Laboratories, Inc., Abaxis, Inc., Myriad Genetics, Inc., Ortho Clinical Diagnostics and Quidel Corporationbut this major new report looks at all 100 of the top companies - companies like - GenMark Diagnostics, Inc. - GenMark Diagnostics, Inc. (NASDAQ: GNMK) is a leading provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. The Company's XT-8® system is designed to support a broad range of molecular diagnostic tests with a compact, easy-to-use workstation and self-contained, disposable test cartridges. As of December 31, 2015, GenMark had an installed base of 633 XT-8® systems, or placements, with their customers. In June, 2016, the Company achieved the CE Mark for its ePlex sample-to-answer multiplex molecular diagnostics System and ePlex Respiratory Pathogen (RP) Panel. GenMark is headquartered in Carlsbad, California, United States, had annual revenue of $39.4 million in 2015 and has 233 employees. The Company is led by Hany Massarany, President And Chief Executive Officer.

Report data field structure is as follows:


  • Company Name

  • Address

  • Telephone

  • Fax

  • Email

  • Website

  • Year Established

  • Number of Employees

  • Key Executives

  • Company Description

  • Products

  • Clinical Specialties/Diseases

  • Diagnostic Disciplines

  • Revenue ($U.S. million)

  • Location Status

  • Ownership

  • Stock Exchange/Ticker Symbol

  • Parent Company

The Top 100 U.S. In-Vitro Diagnostics Companies

Table of Contents

N/A

  • Asia Pacific Makeup Market To Grow Owing To Impactful Promotion And Progress Of Distribution Networks
    The Asia Pacific makeup market is one of the most assorted and active markets in the cosmetics industry throughout the world and is projected to grow at a CAGR of 7.1% between 2013 and 2019. The makeup market in Asia Pacific is assessed to be worth US$22.31 billion by 2019. The world-wide market was at an approximation of US$14.76 [...]
  • Growing Demand in Emergent Markets To Boost Bakery Ingredients Market
    The baking ingredients market is predictable to grow at a CAGR of 5.2% from 2015 to reach an estimated value of US$ 15.19 billion by 2020. Evolving economies throughout the globe have been displaying demand for bakery ingredients at a greater rate in agreement with the economic growth. Numerous companies have been occupied on refining [...]
  • Packaging Sector Driven By Innovation
    The financial development in numerous emerging nations has significantly influenced the progress of quite a lot of sectors, the packaging industry being one of them. The swell in transport undertakings outfitting to a substantial number of industries such as manufacturing, consumer goods, food and beverages, and others rest essentially on sturdy and resilient packaging solutions [...]
  • Global Eyewear Market To Gain From Increased Demand For Disposable Contact Lenses
    The global eyewear market was worth US$ 102.66 billion in 2015 and is predictable to reach US$ 184.03 billion by 2024. The rising population and upsurge in the number of optical disorders are likely to propel the industry in the near future. Moreover, the increasing cognizance amongst people as regards to the prominence of eye [...]
  • Global mHealth Market To Become A Multi-Billion Dollar Industry By 2020
    The mHealth market is in its embryonic stage and is projected to produce substantial profits with amassed awareness level and encouraging regulatory guidelines particular to the quality and practicality of mobile-based medical devices. The global mHealth market is projected to touch US$ 49.12 billion by 2020 rising at a CAGR of 47.6% from 2013 to 2020. Monitoring services [...]
  • In-Vitro Diagnostics Market Global Briefing 2017 Including: Point-of-Care Diagnostics, Immunochemistry, Molecular Diagnostics, Microbiology, Hematology and Immunohematology Covering: Siemens Healthineers, Abbott Laboratories Inc., Thermo Fisher Scientific, Inc., Sysmex Corporation
    Published: 06-Feb-2017        Price: US 1000 Onwards        Pages: 26
    In-vitro diagnostics (IVD) are used to detect diseases, infections, and conditions and also monitor a person's state of health and therapeutic procedures by examining specimens derived from the human body such as tissue, blood, stools, urine and the other body fluids. The In-Vitro Diagnostics Market Global Briefing provides strategists, marketers and senior management with the critical information they need to assess the global in-vitro diagnostics market. Reasons t......
  • The Top 600 In-Vitro Diagnostics Companies Worldwide:
    Published: 26-Jan-2017        Price: US 5005 Onwards        Pages: 1051
    Did you know? Transasia Bio-Medicals is India’s largest in-vitro diagnostics company. Diachel SA is the leading independent in-vitro diagnostics distributor in Greece, offering complete laboratory solutions, from sales to after-sales support and service. Una Health Ltd., the fastest growing diagnostics distributor in the United Kingdom, specialises in bringing innovative point-of-care devices to the market. Abbott Diagnostics......
  • 2017 Emerging Immunodiagnostic Tests, and Strategic Profiles of Leading Reagent and Instrument Suppliers
    Published: 24-Jan-2017        Price: US 3950 Onwards        Pages: 240
    This 240-page report presents an overview of the clinical significance and market needs for major Chemistry, TDM, Endocrine, Cancer, Immunoprotein, and Abused Drug assays, including listings of companies developing or marketing new technologies and products.The report also presents strategic assessments of current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product portfolios, marketing tactics, technological know-ho......
  • 2017-2021 US In Vitro Diagnostics Market: Strategic Implications of Emerging Reimbursement, Technological and Market Trends
    Published: 24-Jan-2017        Price: US 4850 Onwards        Pages: 135
    - How will the future reimbursement changes affect individual market segments?- Will the industry consolidate, decentralize, or undergo a bimodal transformation?- What will be the impact on purchasing influences, marketing strategies, joint ventures, mergers, licensing, import and export?- How will the future technological advances affect the major market segments?- Which companies will enter the market and which will not survive?These and other key strategic issues faci......
  • 2017-2021 World Sexually-Transmitted Disease (STD) Diagnostics Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis--Supplier Shares, Sales Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation
    Published: 24-Jan-2017        Price: US 9600 Onwards        Pages: 350
    About this ReportThis report presents a detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.  Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.  The report provides test volume and sales forecasts by country and market segment, including:     - Hospitals......
  • 2017-2021 Cell Surface Markers: US, Europe (France, Germany, Italy, Spain, UK), Japan--Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities
    Published: 24-Jan-2017        Price: US 5350 Onwards        Pages: 120
    The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next ten years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself. This repo......
  • 2017-2021 US Enteric Disease Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
    Published: 24-Jan-2017        Price: US 3850 Onwards        Pages: 322
    About This ReportThis new 322-page report from VPGMarketResearch.com presents detailed analysis of the US Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia.  The report provides test volume and sales projections for Hospitals, Physician Offices, Commercial and Public Health Labs.    In add......
  • 2017-2021 UK Enteric Disease Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
    Published: 24-Jan-2017        Price: US 2200 Onwards        Pages: 322
    About This ReportThis new 322-page report from VPGMarketResearch.com presents detailed analysis of the UK Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia.  The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs. In addition to market share and sales forec......
  • 2017-2021 Spain Enteric Disease Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
    Published: 24-Jan-2017        Price: US 2200 Onwards        Pages: 322
    About This ReportThis new 322-page report from VPGMarketResearch.com presents detailed analysis of the Spanish Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.  In addition to market share and sales f......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs